# ZYMFENTRA

NDC: 72606-047
Generic name: infliximab-dyyb
Labeler / Manufacturer: CELLTRION USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20240301

FDA application: BLA761358

## Active ingredients

- INFLIXIMAB-DYYB: 120 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72606-047"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72606-047
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=93a193ab-9f96-4da6-aa7c-31212e81879a